The SEC had settled charges against Houston-based biotherapeutics company Kiromic BioPharma, Inc., its former CEO, Maurizio Chiriva-Internati, and its former chief financial officer, Tony Tontat, for failing to disclose material information about Kiromic’s two cancer-fighting-drug candidates before, during, and after ...
Home/kiromic biopharma inc